COR:NYE-CoreSite Realty Corporation (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 242.99

Change

-1.65 (-0.67)%

Market Cap

USD 2.35B

Volume

1.57M

Analyst Target

USD 128.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CoreSite Realty Corp is a fully integrated, self-administered and self-managed real estate investment trust. The Company is engaged in the business of owning, acquiring, constructing and managing technology-related real estate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
MCK McKesson Corporation

N/A

USD 70.80B
CAH Cardinal Health Inc

N/A

USD 26.32B
OMI Owens & Minor Inc

N/A

USD 2.06B
NVG Nuveen AMT Free Municipal Cred..

N/A

USD 3.29M

ETFs Containing COR

BLOV:CA Brompton North American L.. 4.33 % 0.00 %

N/A

CAD 9.64M
BMED BlackRock Future Health E.. 3.21 % 0.00 %

N/A

USD 4.21M
FLOW Global X Funds 2.16 % 0.00 %

N/A

USD 4.11M
PGAL 0.00 % 0.57 %

N/A

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.31% 80% B- 89% A-
Dividend Return 0.25% 50% F 13% F
Total Return 18.56% 80% B- 89% A-
Trailing 12 Months  
Capital Gain 43.43% 40% F 88% B+
Dividend Return 0.60% 25% F 6% D-
Total Return 44.04% 40% F 87% B+
Trailing 5 Years  
Capital Gain 127.05% 40% F 89% A-
Dividend Return 14.79% 60% D- 57% F
Total Return 141.84% 40% F 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.29% 40% F 80% B-
Dividend Return 17.05% 40% F 81% B-
Total Return 2.76% 60% D- 58% F
Risk Return Profile  
Volatility (Standard Deviation) 14.62% 100% F 70% C-
Risk Adjusted Return 116.64% 80% B- 99% N/A
Market Capitalization 2.35B 80% B- 93% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 47.80 80% 33%
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio 9.85 50% 37%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 233.66% 100% 100%
Return on Invested Capital 35.20% 80% 95%
Return on Assets 2.70% 60% 52%
Debt to Equity Ratio 622.27% 20% 4%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.